Home  >  Products  >  SH2D4A (SH2 domain containing 4A ) Blocking Peptide (the N terminal of SH2D4A)(100ug)
SH2D4A (SH2 domain containing 4A ) Blocking Peptide (the N terminal of SH2D4A)(100ug)

SH2D4A (SH2 domain containing 4A ) Blocking Peptide (the N terminal of SH2D4A)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-SH2D4A Antibody (ARP66275_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP66275
Size: 100ug
Weight: 53kDa
Gene: 63898
Format: Lyophilized powder
Target: SH2D4A inhibits estrogen-induced cell proliferation by competing with PLCG for binding to ESR1, blocking the effect of estrogen on PLCG and repressing estrogen-induced proliferation. SH2D4A may play a role in T-cell development and function.
Alternative names: FLJ20967; SH2A
See Full Product Listings >